Ignite Creation Date:
2024-05-06 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06191900
Status:
RECRUITING
Last Update Posted:
2024-01-05
First Post:
2023-12-20
Brief Title:
Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors Advanced Cervical Cancer
Sponsor:
Grit Biotechnology
Organization:
Grit Biotechnology
Study Overview
Official Title:
Single Arm Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection GT201 in the Treatment of Advanced Gynecological Tumors Advanced Cervical Cancer
Status:
RECRUITING
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is an early exploration clinical study with one arm
The study consists of two stages namely the dose escalation stage and the dose extension stage
The study consists of two stages namely the dose escalation stage and the dose extension stage
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None